GlassScriptPhysician profile
Prethi Vaddadi
NPI 1780810614
$330.44
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $210 · 2020: $42.61 · 2021: $77.83.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $107.10 | 2019-2021 | |
| Avanos Medical | $57.59 | 2019 | |
| Daiichi Sankyo INC. | $46.89 | 2019-2021 | |
| Gilead Sciences, INC. | $38.41 | 2019 | |
| Amgen INC. | $24.74 | 2019 | |
| Novo Nordisk INC | $15.80 | 2019 | |
| Olympus America INC. | $14.83 | 2020 | |
| Therapeuticsmd, INC. | $14.04 | 2019 | |
| Teleflex LLC | $11.04 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prethi Vaddadi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.